PICO Portalanswers from OpenAlex & ORCID
Peter Hau
ResearcherPublications, citations & collaboration network
Peter Hau is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Peter Hau have?
PICO Portalindexed works
Peter Hau has 425 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Peter Hau have?
PICO Portalcitation count
Peter Hau has 29,774 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Peter Hau?
PICO Portalh-index
Peter Hau has an h-index of 57 in OpenAlex.
What is the i10-index of Peter Hau?
PICO Portali10-index
Peter Hau has an i10-index of 156 in OpenAlex.
What is the ORCID of Peter Hau?
PICO Portalorcid
The ORCID for Peter Hau is on the source record.
What is the OpenAlex record for Peter Hau?
PICO Portalopenalex
The OpenAlex for Peter Hau is on the source record.
What are the most-cited papers on Peter Hau?
PICO Portalmost cited works
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
Ulrich Herrlinger, Theophilos Tzaridis, Frederic Mack, Joachim P. Steinbach, Uwe Schlegel, Michael Sabel, Peter Hau, Rolf‐Dieter Kortmann, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Oliver Schnell, Oliver Bähr, Martin Uhl, Clemens Seidel, Ghazaleh Tabatabai, Thomas E. Kowalski, Florian Ringel, Friederike Schmidt‐Graf, Bogdana Suchorska, Stefanie Brehmer, Astrid Weyerbrock, Miriam Renovanz, Lars Bullinger, Norbert Galldiks, Peter Vajkoczy, Martin Misch, Hartmut Vatter, Moritz Stuplich, Niklas Schäfer, Sied Kebir, Johannes Weller, Christina Schaub, Walter Stummer, Jörg‐Christian Tonn, Matthias Simon, Vera C. Keil, Michael Nelles, Horst Urbach, Martin Coenen, Wolfgang Wick, Michael Weller, Rolf Fimmers, Matthias Schmid, Elke Hattingen, Torsten Pietsch, Christoph Coch, Martin Glas
Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
Ulrich Bogdahn, Peter Hau, Günther Stockhammer, N. K. Venkataramana, Anuspandana Mahapatra, Ashish Suri, Anandh Balasubramaniam, Sujit Nair, V. Oliushine, В. Е. Парфенов, И. Е. Повереннова, Menashe Zaaroor, Piotr Jachimczak, S. Ludwig, S. Schmaus, H. Heinrichs, K.-H. Schlingensiepen, the Trabedersen Glioma Study Group
Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies
Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen, Frank Schulmeyer, Tanya Jauch, Andreas Steinbrecher, Alexander Brawanski, Martin Proescholdt, Jürgen Schlaier, Johanna Buchroithner, Josef Pichler, Gabriele Wurm, H. Maximilian Mehdorn, Rainer J. Strege, Gerhard Schuierer, Victoria Villarrubia, Franz A. Fellner, Olav Jansen, Thorsten Straube, Virinder Nohria, Michael Goldbrunner, M. Kunst, S. Schmaus, G. Stauder, Ulrich Bogdahn, Karl‐Hermann Schlingensiepen